Back
NovoCure Stock Price Chart
Sponsored
NVCR
Sponsored
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
47
NVCR
NovoCure
Last Price:
14.77
Seasonality Move:
6.82%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.
NovoCure Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.99 | Buy |
20-day SMA: | 13.03 | Buy |
50-day SMA: | 14.19 | Buy |
200-day SMA: | 17.01 | Sell |
8-day EMA: | 13.31 | Buy |
20-day EMA: | 13.21 | Buy |
50-day EMA: | 13.76 | Buy |
200-day EMA: | 22.18 | Sell |
NovoCure Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 61.74 | Buy |
Chaikin Money Flow: | -175369 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.21 - 14.43) | Buy |
Bollinger Bands (100): | (12.95 - 15.47) | Buy |
NovoCure Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NovoCure Stock
Is NovoCure Stock a Buy?
- NovoCure share price is 14.78 while NVCR 8-day simple moving average is 12.99, which is a Buy signal.
- The stock price of NVCR is 14.78 while NovoCure 20-day SMA is 13.03, which makes it a Buy.
- NovoCure 50-day simple moving average is 14.19 while NVCR share price is 14.78, making it a Buy technically.
- NVCR stock price is 14.78 and NovoCure 200-day simple moving average is 17.01, creating a Sell signal.
NVCR Technical Analysis vs Fundamental Analysis
NovoCure Stock Info
Market Cap:
1.59B
Price in USD:
14.78
Share Volume:
1.15M
NovoCure 52-Week Range
52-Week High:
83.60
52-Week Low:
10.87
Sell
47
NovoCure (NVCR)
is a Sell
NovoCure Share Price Forecast
-
What is the NovoCure stock price today?
The NovoCure stock price is 14.78 USD today. -
Will NVCR stock go up or go down?
NovoCure> share price is forecast to RISE/FALL based on technical indicators -
Is NovoCure overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is overvalued.
Is NovoCure Stock a Buy?
- NovoCure share price is 14.78 while NVCR 8-day exponential moving average is 13.31, which is a Buy signal.
- The stock price of NVCR is 14.78 while NovoCure 20-day EMA is 13.21, which makes it a Buy.
- NovoCure 50-day exponential moving average is 13.76 while NVCR share price is 14.78, making it a Buy technically.
- NVCR stock price is 14.78 and NovoCure 200-day simple moving average is 22.18, creating a Sell signal.
Fundamental Analysis of NovoCure
Is NovoCure a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.44 per share, and a decrease next year of $0.20 per share.
Technical Analysis of NovoCure
Should I short NovoCure stock?
- NVCR Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting NovoCure is a Sell
- NovoCure Relative Strength Index (RSI) is 61.74, which suggest NovoCure is overbought
- The Bollinger Bands (25) for NovoCure is (12.21 - 14.43), which suggest NovoCure is a Buy
- The Bollinger Bands (100) for NovoCure is (12.95 - 15.47), which suggest NovoCure is a Buy
* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.